Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Oct 13, 2010

Premium

Celera has announced the departure of its Senior VP and Chief Financial Officer Ugo DeBlasi in November. DeBlasi will leave following presentation of the firm's third-quarter financial report. The Alameda, Calif.-based firm said DeBlasi is leaving his position in order to be closer to his family in Connecticut.



Life Technologies
has appointed Paul Billings to step into the role of chief medical officer, a new position at the company that was created to develop ways to use genomics technologies, specifically next-generation sequencing tools, in clinical settings. He also will represent Life Technologies’ diagnostic products and technologies to physicians, payers, patients, and regulators.

Billings recently served as director and chief scientific officer at the Genomic Medicine Institute at El Camino Hospital, and he currently is a member of the Secretary’s Advisory Committee on Genetics, Health, and Society in the US Department of Health and Human Services, where he helps analyze and make recommendations on genomic medicine policy.

After a career in academics, Billings was a founder or CEO of companies including GeneSage, Omicia, and Cellective Dx, and he served as VP of corporate development at Laboratory Corporation of America.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.